financetom
Business
financetom
/
Business
/
Altria Group to Sell Portion of Anheuser-Busch Inbev Stake Through Global Secondary Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Altria Group to Sell Portion of Anheuser-Busch Inbev Stake Through Global Secondary Offering
Mar 13, 2024 2:09 PM

04:51 PM EDT, 03/13/2024 (MT Newswires) -- Altria Group ( MO ) said Wednesday it plans to sell part of its investment in Anheuser-Busch Inbev ( BUD ) through a global secondary offering.

Altria ( MO ) currently holds approximately 197 million shares of ABI, representing about a 10% stake.

The offering will include separate public offerings for Anheuser-Busch's American depositary shares and ordinary shares in the US, a concurrent private placement of its shares in the European Economic Area and the UK, and an offering of shares in other countries outside the US, according to Altria ( MO ).

Altria ( MO ) said Anheuser-Busch agreed to buy back $200 million of ordinary shares directly from the group.

The board approved the offering and proceeds from the partial stake sale will be used for additional share repurchases, Altria ( MO ) added.

Anheuser-Busch did not immediately respond to MT Newswires' request for comment.

Price: 43.43, Change: +0.08, Percent Change: +0.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MediciNova Completes Enrollment in a Phase 2 Study of Colorectal Cancer Drug
MediciNova Completes Enrollment in a Phase 2 Study of Colorectal Cancer Drug
Mar 10, 2026
06:45 AM EST, 12/18/2025 (MT Newswires) -- MediciNova ( MNOV ) said Thursday it has completed patient enrollment in its phase 2 study evaluating MN-166 for the prevention of chemotherapy-induced peripheral neuropathy in patients with metastatic colorectal cancer. The company said a total of 100 patients were enrolled across two treatment arms at 11 clinical sites in Australia. Participants will...
Tutor Perini Unit Secures Central Utility Plant Expansion Contract From UC Davis Health
Tutor Perini Unit Secures Central Utility Plant Expansion Contract From UC Davis Health
Mar 10, 2026
06:45 AM EST, 12/18/2025 (MT Newswires) -- Tutor Perini ( TPC ) said Thursday that its Rudolph and Sletten subsidiary has secured a contract from UC Davis Health for the Central Utility Plant Expansion in Sacramento, California. The scope of work under the project includes the construction of a new two-story, 32,000-square-foot Central Utility Plant annex building, and renovation of...
Lilly pill maintains weight loss after switching from injectables in trial
Lilly pill maintains weight loss after switching from injectables in trial
Mar 10, 2026
Dec 18 (Reuters) - Eli Lilly's ( LLY ) oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 drugs, the company said on Thursday, in a boost to deliver a more convenient obesity treatment option. An oral weight-loss pill would help Lilly further widen its lead over Novo Nordisk. Both Lilly and Novo are...
Market Chatter: U.S. Lists Demands Canada Must Meet to Extend CUSMA
Market Chatter: U.S. Lists Demands Canada Must Meet to Extend CUSMA
Mar 10, 2026
06:45 AM EST, 12/18/2025 (MT Newswires) -- U.S. trade officials are signalling that Canada will need to make policy changes if it wants long-term certainty under the Canada-U.S.-Mexico Agreement (CUSMA), as the trade deal comes up for mandatory review next year, CTV News reported overnight Wednesday, with files included from the Canadian Press. The report noted U.S. Trade Representative Jamieson...
Copyright 2023-2026 - www.financetom.com All Rights Reserved